MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock
$2,990,361
Proceeds from exercised
warrants
$507,035
Offering costs paid
-$483,905
Net cash provided by
(used in) financing...
$3,343,344
Canceled cashflow
$637,957
Net increase
(decrease) in cash and cash...
$2,113,587
Canceled cashflow
$1,229,757
something is missing
-$573,616
Principal payments on
notes payable
$57,557
Taxes paid related to
net share...
-$6,784
Stock-based compensation
$329,434
Accounts payable
$165,932
Accrued expenses
$68,213
Issuance of common stock
for non-cash...
$50,001
Prepaids and other
current assets
-$39,119
Change in fair value of
warrant liability
$31,506
Inventory
-$25,326
Depreciation and
amortization
$16,317
Non-cash lease expense
$16,215
Customer deposits
$925
Net cash used in
operating activities
-$1,229,757
Canceled cashflow
$742,988
Net revenue
$1,607,883
Net loss
-$1,761,432
Accounts receivable
$189,200
Operating lease liability
-$15,531
Provisions for losses on
inventory
-$6,476
Provisions for losses on
accounts receivable
-$106
Gross profit
$1,389,517
Other income
$36,942
Canceled cashflow
$218,366
Operating loss
-$1,740,679
Total other (expense)
income, net
-$20,753
Canceled cashflow
$1,389,517
Canceled cashflow
$36,942
Cogs
$218,366
Compensation and benefits
$1,412,665
Selling expenses
$824,336
Change in fair value of
warrant liability
$31,506
Professional services
$436,303
Other operating
expenses
$341,007
Research & development
$99,567
Amortization
$8,284
Depreciation
$8,034
Interest expense
$26,189
Back
Back
Cash Flow
source: myfinsight.com
Neuraxis, INC (NRXS)
Neuraxis, INC (NRXS)